Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering Business Wire
Tenax Therapeutics, Inc. (NASDAQ: TENX) announces the pricing of an underwritten offering for gross proceeds of approximately $10 million.
Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering Business Wire
Tenax Therapeutics, Inc. (NASDAQ: TENX) announces the pricing of an underwritten offering for gross proceeds of approximately $10 million.